In addition, GIP signaling has been implicated in the regulation of lipid metabolism, with evidence suggesting a role in promoting lipid utilization and improving insulin sensitivity in metabolically active tissues
While SGLT2 inhibitors have demonstrated significant benefits across metabolic, cardiovascular, and renal pathways, no established guidelines currently recommend their routine use in CMS patients
However, research into glutathione benefits remains scarce
With the new category of drugs, the weight-loss outcomes are so much better, and we listen to our users, our patients, said Linda Anegawa, Nooms chief of medicine
has received speaker/consultancy fees from Boehringer Ingelheim, Janssen, Karuna, Lundbeck, Otsuka and Viatris, and co-directs a company that designs digital resources to support treatment of mental ill health